Abstract:Background: Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan-dioxygenase (TDO) are enzymes catabolizing the essential amino acid tryptophan into kynurenine. Expression of these enzymes is frequently observed in advanced-stage cancers and is associated with poor disease prognosis and immune suppression. Mechanistically, the respective roles of tryptophan shortage and kynurenine production in suppressing immunity remain unclear. Kynurenine was proposed as an endogenous ligand for the aryl hydrocarbon receptor (AHR), which can regulate inflammation and immunity. However, controversy remains regarding the role of AHR in IDO1/TDO-mediated immune suppression, as well as the involvement of kynurenine. In this study, we aimed to clarify the link between IDO1/TDO expression, AHR pathway activation and immune suppression. Methods: AHR expression and activation was analyzed by RT-qPCR and western blot analysis in cells engineered to express IDO1/TDO, or cultured in medium mimicking tryptophan catabolism by IDO1/TDO. In vitro differentiation of naïve CD4+ T cells into regulatory T cells (Tregs) was compared in T cells isolated from mice bearing different Ahr alleles or a knockout of Ahr, and cultured in medium with or without tryptophan and kynurenine. Results: We confirmed that IDO1/TDO expression activated AHR in HEK-293-E cells, as measured by the induction of AHR target genes. Unexpectedly, AHR was also overexpressed on IDO1/TDO expression. AHR overexpression did not depend on kynurenine but was triggered by tryptophan deprivation. Multiple human tumor cell lines overexpressed AHR on tryptophan deprivation. AHR overexpression was not dependent on general control non-derepressible 2 (GCN2), and strongly sensitized the AHR pathway. As a result, kynurenine and other tryptophan catabolites, which are weak AHR agonists in normal conditions, strongly induced AHR target genes in tryptophan-depleted conditions. Tryptophan depletion also increased kynurenine uptake by increasing SLC7A5 (LAT1) expression in a GCN2-dependent manner. Tryptophan deprivation potentiated Treg differentiation from naïve CD4+ T cells isolated from mice bearing an AHR allele of weak affinity similar to the human AHR. Conclusions: Tryptophan deprivation sensitizes the AHR pathway by inducing AHR overexpression and increasing cellular kynurenine uptake. As a result, tryptophan catabolites such as kynurenine more potently activate AHR, and Treg differentiation is promoted. Our results propose a molecular explanation for the combined roles of tryptophan deprivation and kynurenine production in mediating IDO1/TDO-induced immune suppression.

The high-affinity tryptophan uptake transport system in human cells

Tryptophan Metabolism in Health and Disease

Heme-containing Enzymes and Inhibitors for Tryptophan Metabolism

Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes

Effects of the tryptophan 2,3-dioxygenase in tryptophan metabolism and immunoregulation

Systemic tryptophan homeostasis

Tryptophan potentiates CD8 + T cells against cancer cells by TRIP12 tryptophanylation and surface PD-1 downregulation

The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity

Tryptophan (Trp) modulates gut homeostasis via aryl hydrocarbon receptor (AhR)

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?

Interferon-γ Up-Regulates Expressions of Indoleamine 2,3-Dioxygenase and Tryptophanyl-Trna-synthetase in Human Thyrocytes

Tryptophan-Degrading Enzymes in Tumoral Immune Resistance

Tryptophan depletion results in tryptophan-to-phenylalanine substitutants

Ido expression by dendritic cells: tolerance and tryptophan catabolism

Unveiling Tryptophan Dynamics and Functions Across Model Organisms via Quantitative Imaging

Effects of the Indoleamine 2,3- Dioxygenase- Initiated L- Tryptophan Metabolism in Organ Transplantation

Tumoral Immune Resistance Mediated by Enzymes That Degrade Tryptophan

Tryptophan metabolism through indoleamine 2,3-dioxygenase/tryptophanyl t-RNA sythetase metabolic pathway effects proliferation of synovial autoreactive T cells in rheumatoid arthritis

Tryptophan and the innate intestinal immunity: Crosstalk between metabolites, host innate immune cells, and microbiota

Oral tryptophan activates duodenal aryl hydrocarbon receptor in healthy subjects: a crossover randomized controlled trial

Species Differences in Tryptophan Metabolism and Disposition